VIP dosage guide

VIP dosage chart

This summary table compares available dose amounts and schedules by administration route.

Route	Dose	Frequency & duration
Injectable	50–100 mcg	1–2x daily · 3–6 mo
Intranasal	~50 mcg	2x daily · 3–6 mo
Inhaled	100 mcg per nebulized administration	Two administrations 30 minutes apart, once daily · 7–14 days

VIP dosage by administration route

VIP injectable dosage

Reported-use amounts for VIP are 50–100 mcg per administration, 1–2x daily, for 3–6 mo.[9]

VIP is a vasoactive peptide with effects on vascular tone, airway signaling and secretion. Those effects make blood pressure and route-specific delivery important considerations.[1][2][3][9]

VIP intranasal dosage

Reported-use amounts for VIP are ~50 mcg per administration, 2x daily, for 3–6 mo.[9]

VIP is a vasoactive peptide with effects on vascular tone, airway signaling and secretion. Those effects make blood pressure and route-specific delivery important considerations.[1][2][3][9]

VIP inhaled dosage

A documented investigational inhaled aviptadil regimen uses two 100 mcg administrations 30 minutes apart, once daily for 7–14 days, totaling 200 mcg per day. It uses a specific mesh-nebulizer formulation in hospital-based COVID-19 pneumonia care, rather than a general-use VIP spray or infusion.[5]

VIP is a vasoactive peptide with effects on vascular tone, airway signaling and secretion. Those effects make blood pressure and route-specific delivery important considerations.[1][5][2][3]

Frequency and timing

Morning or evening is the listed timing for injections and nasal use. The inhaled aviptadil regimen uses two administrations 30 minutes apart, once daily.[4][1][2][9][5]

Cycle length and breaks

Injectable: 3–6 mo. Intranasal: 3–6 mo. Inhaled: 7–14 days. A standard break interval between courses is not established.[9][5]

VIP dosage calculator

Convert your chosen VIP amount into volume and U-100 syringe units. Adjust the inputs to match your vial and preparation.

VIP safety and side effects

Approval and product quality

VIP is not an FDA-approved drug.[4][6][7][8]

Side effects and long-term safety

Flushing, headache, dizziness and blood-pressure effects are practical tolerability concerns. Long-term repeated use, disease-specific benefit-risk, intranasal absorption and compounded-product quality remain uncertain.[1][2][3]

Route-specific dosing limits

Blood pressure, cardiovascular disease, pulmonary disease, and product route are the main safety contexts. Reported-use injectable and intranasal schedules are not established human treatment regimens.[1][2][3][9]

Common VIP dosage questions

Can VIP doses be transferred between routes?

No. Each route and formulation has its own exposure and administration requirements. Use the dose information for the exact presentation rather than copying a tablet, injection or local-product amount to another route.[4][1][2][5]

What dosage is listed for VIP?

Reported-use amounts for VIP are 50–100 mcg per administration, 1–2x daily, for 3–6 mo.[9]

Does VIP have a standard cycle or break interval?

Injectable: 3–6 mo. Intranasal: 3–6 mo. Inhaled: 7–14 days. A standard break interval between courses is not established.[9][5]